Douglas E. Coltharp - Aug 13, 2024 Form 4 Insider Report for Encompass Health Corp (EHC)

Role
EVP & Chief Financial Officer
Signature
/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp
Stock symbol
EHC
Transactions as of
Aug 13, 2024
Transactions value $
-$619,199
Form type
4
Date filed
8/14/2024, 03:03 PM
Previous filing
Jul 2, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EHC Encompass Health Common Stock Options Exercise $439K +12.3K +9% $35.83 148K Aug 13, 2024 Direct
transaction EHC Encompass Health Common Stock Sale -$1.05M -12.2K -8.19% $86.33 136K Aug 13, 2024 Direct F1
transaction EHC Encompass Health Common Stock Sale -$8.53K -98 -0.07% $87.03 136K Aug 13, 2024 Direct F2
holding EHC Encompass Health Common Stock 126K Aug 13, 2024 By irrevocable trust for the benefit of children

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EHC Non-qualified Stock Option (Right to Buy) Options Exercise $0 -12.3K -100% $0.00* 0 Aug 13, 2024 Encompass Health Common Stock 12.3K $35.83 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.93 to $86.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F2 This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $87.03 to $87.04, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F3 The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.